Search Results
Results found for "Brian E Krumm"
- Dr. Mark Connor | Dr. GPCR Ecosystem
properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
in immune cells and insulin-sensitive tissues (liver, pancreas, skeletal muscle, adipose tissue, and brain
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
Remulate, a neuronal adhesion GPCR with a human ortholog linked to vascular malformations and blood-brain The human ortholog has been associated with vascular malformations and blood-brain barrier dysfunction
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Bryan Roth (current) Dr. Ali Salahpour (2007) Dr. Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.
- Dr. Raul Gainetdinov | Dr. GPCR Ecosystem
Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why GPCR drug discovery is the biology, not the chemistry. << Back to podcast list Strategic Partner(s) Bryan Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Join me and learn more about Bryan and his work. Dr. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
intake regulation, and inflammation — within complex tissue environments including the pancreas and brain
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
emphasis on understanding how these receptors operate within complex tissues such as the pancreas and brain
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
shared an example she heard in a podcast about fecal transplants and the relationship between the gut, brain
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
“Your brain’s not a machine. Let it rest.
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
The ideal delta agonist, by her account, would be non-internalizing, brain-penetrant, long-half-life,
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
cells in an age of iPSC enthusiasm 30:40 — Cannabinoids, the entourage hypothesis, and THC in teenage brains
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
molecular logic of synapse formation and how adhesion molecules encode synaptic specificity in the brain
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
It’s highly expressed in the brain and spinal cord.
